https://www.selleckchem.com/products/myk-461.html
sTLR2 and sTLR4 might be diagnostic and prognostic biomarkers for NHL. sTLR2 and sTLR4 might be diagnostic and prognostic biomarkers for NHL. Combinations of 5-fluorouracil/leucovorin (5-FU/LV) with oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are part of standard treatments for metastatic colorectal cancer (mCRC). For these molecules, the impact of a low relative dose intensity (RDI) on survival is not sufficiently known in real-life. Data were collected retrospectively from patients treated in our center for an unresectable mCRC with
Like
Comment
Share
